#DIA2018 | Microsoft's Desmond Creary on how Savings from Innovation Can Fuel R&D
From the floor at #DIA2018 - Microsoft Health Leader Desmond Creary explores how savings from innovation can help fuel greater R&D investment.
#DIA2018 | Microsoft's Desmond Creary on the PAREXEL Alliance
From the floor at #DIA2018 - Microsoft Health Leader Desmond Creary shares his perspective on how PAREXEL's alliance with Microsoft can help to move the drug development industry forward.
Intelligent Clinical Trials: How Technology Will Transform Clinical Trials
How Technology Will Transform Clinical Trials To Lower Costs, Reduce Time To Market And Provide Value To The Patient.
Decoding Insights from Wearables in Clinical Trials Where to Start
Within clinical trials, there is optimism that connected wearables, sensors and other medical devices can be used to collect novel endpoints to give greater insight into a study subject’s health statu
PAREXEL Informatics: Decoding Data into Insights
PAREXEL® Informatics is at the forefront of innovation and driving evolution by looking at technology and data differently. Our breadth and depth of expertise partnered with modern technology means we
Perceptive Cloud - Addressing Today's Needs And Tomorrow's Challenges
PAREXEL’s Perceptive® Cloud, built on Microsoft Azure, delivers technology solutions at a predictable cost, on a secure cloud platform.
Leveraging The Cloud To Accelerate Time To Treatment
Through a shared data platform built on a cloud computing model PAREXEL can enable efficiencies while also addressing the significant privacy, security and compliance challenges that the pharmaceutica
Are You Keeping Pace with Digital Evolution?
As drug development timelines increase and access to data becomes even greater than ever, how is the industry utilizing digital technologies to make for a better future?
Microsoft - PAREXEL Alliance - An Alliance In Support Of Life Sciences
This alliance will accelerate drug development, leveraging PAREXEL’s life science expertise and Microsoft’s high velocity innovation.